Cite
Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
MLA
Bas, M., et al. “Novel Pharmacotherapy of Acute Hereditary Angioedema with Bradykinin B2-Receptor Antagonist Icatibant.” Allergy, vol. 61, no. 12, Dec. 2006, pp. 1490–92. EBSCOhost, https://doi.org/10.1111/j.1398-9995.2006.01197.x.
APA
Bas, M., Bier, H., Greve, J., Kojda, G., & Hoffmann, T. K. (2006). Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Allergy, 61(12), 1490–1492. https://doi.org/10.1111/j.1398-9995.2006.01197.x
Chicago
Bas, M., H. Bier, J. Greve, G. Kojda, and T. K. Hoffmann. 2006. “Novel Pharmacotherapy of Acute Hereditary Angioedema with Bradykinin B2-Receptor Antagonist Icatibant.” Allergy 61 (12): 1490–92. doi:10.1111/j.1398-9995.2006.01197.x.